Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) 5-Year EBITDA Growth Rate : 5.50% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co 5-Year EBITDA Growth Rate?

Jiangsu Jibeier Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.32.

During the past 12 months, Jiangsu Jibeier Pharmaceutical Co's average EBITDA Per Share Growth Rate was 44.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 16.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jiangsu Jibeier Pharmaceutical Co was 16.40% per year. The lowest was -9.50% per year. And the median was 5.50% per year.

Competitive Comparison of Jiangsu Jibeier Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Jibeier Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.

Jiangsu Jibeier Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Jiangsu Jibeier Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000

Website

http://www.jibeier.com.cn

Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.

Executives

Wu Ying	senior management
Zhang Chun	Director
Zhao Suo Fu	senior management
Li Hai Dao	Core technical personnel
Di Jian Zhong	senior management
Qin Xu Feng	Core technical personnel
Wu Xiu Gen	Core technical personnel
Yu Xin Jun	Directors, senior managers
Hu Tao	Director

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Headlines

No Headlines